|Organization:||Massachusetts Health Policy Commission|
M.G.L. c. 6D, § 8A
M.G.L. c. 118E, § 12A
|Official Version:||Purchase the official version|
This regulation specifies the procedures by which the Commission may review information relative to a Referred Manufacturer's pricing practices and determine whether its pricing of a Drug is unreasonable or excessive in relation to the Drug's value.